Universitas Andalas - Research Directory

Real-world progression-free survival of first line afatinib patients with EGFR-mutant advanced lung adenocarcinoma: A multicentre study in Indonesia
Fakultas Kedokteran
First Author: Soeroso N.N.
Authors: SABRINA ERMAYANTI
Q2 Journal |Cancer Treatment and Research Communications
2025
Prognostic role of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in critically ill COVID-19 patients: A retrospective study
Fakultas Kedokteran
First Author: Wulandari W.
Authors: SABRINA ERMAYANTI
Q3 Journal |Medical Journal of Malaysia
2024
Tricky sepsis biomarker: Extremely high procalcitonin in squamous cell lung cancer with doubtful infection
Fakultas Kedokteran
First Author: Ermayanti S.
Authors: SABRINA ERMAYANTI
Q4 Journal |Respirology Case Reports
2023
Survival of COVID-19 Patients Who Received Antiviral and Antiviral Therapy Combined with Anti-inflammation Therapy in a National Referral Hospital, Indonesia
Fakultas Kedokteran
First Author: Afriani A.
Authors: SABRINA ERMAYANTI
Non Q Journal |Open Access Macedonian Journal of Medical Sciences
2022
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
Fakultas Kedokteran
First Author: Sterne J.A.C.
Authors: SABRINA ERMAYANTI
Q1 Journal |Lancet
2022
Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed indonesian lung cancer patients
Fakultas Kedokteran
First Author: Syahruddin E.
Authors: SABRINA ERMAYANTI
Q3 Journal |Lung Cancer Targets and Therapy
2018

Real-world progression-free survival of first line afatinib patients with EGFR-mutant advanced lung adenocarcinoma: A multicentre study in Indonesia

Prognostic role of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in critically ill COVID-19 patients: A retrospective study

Tricky sepsis biomarker: Extremely high procalcitonin in squamous cell lung cancer with doubtful infection

Survival of COVID-19 Patients Who Received Antiviral and Antiviral Therapy Combined with Anti-inflammation Therapy in a National Referral Hospital, Indonesia

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed indonesian lung cancer patients